Treatment of Ocular Mucous Membrane Pemphigoid with Immunosuppressive Drug Therapy

Ophthalmology

Volumn 115, Issue 12, 2008, Pages

  Thorne, Jennifer E ^a,b   Woreta, Fasika A ^a   Jabs, Douglas A ^a,b   Anhalt, Grant J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BASAL CELL CARCINOMA; BLADDER CARCINOGENESIS; BREAST CARCINOMA; COHORT ANALYSIS; CONJUNCTIVA; DISEASE CONTROL; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG UTILIZATION; DRUG WITHDRAWAL; ESOPHAGUS DISEASE; EYE INFLAMMATION; EYELID; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LARYNX CARCINOMA; LEUKEMIA; LEUKOCYTE COUNT; LEUKOPENIA; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MUCOUS MEMBRANE PEMPHIGOID; OCULAR MUCOUS MEMBRANE PEMPHIGOID; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PUNCTATE KERATITIS; RECURRENT DISEASE; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; SCAR FORMATION; SIDE EFFECT; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; THRUSH; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRICHIASIS; UNIVARIATE ANALYSIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VISUAL ACUITY;

EID: 56549109410     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.08.002     Document Type: Article

References (21)

1. Foster C.S. Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84 (1986) 527-561
2. Thorne J.E., Anhalt G.J., and Jabs D.A. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111 (2004) 45-52
3. Miserocchi E., Baltatzis S., Roque M.R., et al. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 109 (2002) 111-118
4. Foster C.S., and Sainz de la Maza M. Ocular cicatricial pemphigoid review. Curr Opin Allergy Clin Immunol 4 (2004) 435-439
5. Ahmed M., Zein G., Khawaja F., and Foster C.S. Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res 23 (2004) 579-592
6. Hingorani M., and Lightman S. Ocular cicatricial pemphigoid. Curr Opin Allergy Clin Immunol 6 (2006) 373-378
7. Chan L.S., Ahmed A.R., Anhalt G.J., et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138 (2002) 370-379
8. Thorne J.E., Anhalt G.J., Jabs D.A., et al. Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid. Ophthalmology 113 (2006) 1651-1656
9. Thorne J.E., Anhalt G.J., and Jabs D.A. Ocular mucous membrane pemphigoid. Dermatol Ther 15 (2002) 389-396
10. Foster C.S., Wilson L.A., and Ekins M.B. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 89 (1982) 340-353
11. Kirtschig G., Murrell D., Wojnarowska F., and Khumalo N. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 138 (2002) 380-384
12. Mondino B.J., and Brown S.I. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 96 (1983) 453-459
13. Tauber J., Sainz de la Maza M., and Foster C.S. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 10 (1991) 185-195
14. McCluskey P., Chang J.H., Singh R., and Wakefield D. Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology 111 (2004) 796-801
15. Sacher C., and Hunzelmann N. Cicatricial pemphigoid (mucous membrane pemphigoid): current and emerging therapeutic approaches. Am J Clin Dermatol 6 (2005) 93-103
16. Letko E., Miserocchi E., Daoud Y.J., et al. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol 111 (2004) 303-310
17. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol 140 (2005) 509-516
18. Kempen J.H., Jabs D.A., Wilson L.A., et al. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 121 (2003) 466-476
19. Thorne J.E., Jabs D.A., Qazi F.A., et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112 (2005) 1472-1477
20. Saw V.P., Dart J.K., Rauz S., et al. Immunosuppressive therapy for ocular mucous membrane pemphigoid: strategies and outcomes. Ophthalmology 115 (2008) 253-261
21. Talar-Williams C., Hijazi Y.M., Walther M.M., et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124 (1996) 477-484